Business ❯Pharmaceutical Industry

Drug Development

Clinical Trials Market Competition Clinical Research Market Trends Weight Loss Drugs FDA Approval Psychedelic Drugs Market Impact Eli Lilly Market Analysis Lykos Therapeutics Market Strategy Market Approval Regulatory Affairs Market Authorization Regulatory Approval Novo Nordisk Research and Development Market Introduction Biopharmaceuticals Research Collaboration Biosimilar Launches Gene Therapies Karuna Therapeutics Mifepristone Ruling Semaglutide Oncology Sales Investor Confidence Drug Pricing Drug Approval Leqembi Tirzepatide Acquisitions ALS Treatment Alzheimer's Drug Development Market Access Liver Disease Treatment Weight-Loss Drug Development FDA Approval Process Clinical Trials Support ALS Treatments Alzheimer's Disease Market Regulation Innovative Medicines Antibody-Drug Conjugates Gene Therapy Cost Analysis Corporate Ethics Psychedelic Companies Investment in Healthcare Clinical Research Organizations Inflation Reduction Act Company Responses Nirsevimab Gilead Sciences Clinical Studies Market Dynamics Antibiotics Production Orphan Drugs Competition Market Demand Market for Addiction Treatments

Australia Subsidizes Esketamine Spray for Treatment-Resistant Depression

Starting May 1, Spravato becomes the first new government-funded antidepressant in 30 years, offering rapid relief but with ongoing cost and access challenges.

Eli Lilly's Oral GLP-1 Pill Demonstrates Success in Phase 3 Trials

EU Regulators Reject Eli Lilly's Alzheimer's Drug Over Safety Concerns

First Death Reported from Sarepta's Duchenne Gene Therapy Raises Safety Concerns

Parkinson’s and RLS Drug Linked to Risky Impulse Behaviors

Novo Nordisk's CagriSema Falls Short in Latest Weight-Loss Trial for Diabetes Patients

FDA Approves Journavx, First Non-Opioid Painkiller in Over 20 Years

Novo Nordisk's Amycretin Shows 22% Weight Loss in Trial, Boosting Stock

Medicare to Cover Eli Lilly’s Zepbound for Sleep Apnea Treatment

FDA Approves Zepbound as First Drug Treatment for Sleep Apnea

Scientists Engineer 'Superman' Bacteria for Sustainable Chemical Production

Novo Nordisk Launches Wegovy in China at Lower Price Point

Scotland Faces Health Crisis Linked to Weight-Loss Injections

Nurse's Death Linked to NHS-Approved Weight-Loss Drug Mounjaro

Novo Nordisk's Oral Semaglutide Shows 14% Reduction in Heart Risks

Experts Urge Action Amid Rising Antibiotic Resistance Crisis

GSK Agrees to $2.2 Billion Settlement Over Zantac Cancer Claims

Wegovy and Ozempic: Celebrity Trends and Health Risks

Pfizer Withdraws Sickle Cell Drug Oxbryta Over Safety Concerns

UCB and Biogen's Lupus Drug Shows Promising Phase 3 Results

New Biannual HIV Injection Reduces Infection Risk by 96%

Lenacapavir Injection Shows 96% Efficacy in Preventing HIV

Novo Nordisk's Amycretin Pill Shows Promising Weight Loss Results in Early Trial

AstraZeneca Under Chinese Compliance Probe; Lung Cancer Drug Trial Results Disappoint

Alnylam's Vutrisiran Shows Mixed Results in Cardiomyopathy Study

FDA Declines MDMA for PTSD Treatment, Requests Further Trials

FDA Rejects MDMA for PTSD Treatment, Requests More Trials

FDA Rejects MDMA for PTSD Treatment, Citing Data Concerns

Henrietta Lacks' Family Files Lawsuit Against Novartis and Viatris Over HeLa Cell Use

Eli Lilly's Zepbound Shows Promise in Reducing Heart Failure Risks

Roche Accelerates Development of Promising Weight-Loss Pills

UK Approves Wegovy for Reducing Heart Risks in Overweight Patients

New HIV Drug Could Revolutionize Prevention at Just $40 Annually

Weight Loss Drug Adherence Drops, Companies Push for Oral Alternatives

Gilead's Lenacapavir Shows 100% Efficacy in HIV Prevention Trial

FDA Faces Critical Decision on MDMA Therapy for PTSD

Insmed's Experimental Drug Brensocatib Achieves Major Trial Success

Roche's Experimental Obesity Drug CT-388 Shows Significant Weight Loss in Early Trials

Eli Lilly Faces Zepbound Shortage, Impacting Weight Loss and Diabetes Patients

Diabetes Drug Lixisenatide Shows Promise in Slowing Parkinson's Progression

AstraZeneca Acquires Fusion Pharmaceuticals in $2.4 Billion Deal to Boost Cancer Treatment Pipeline

FDA Delays Approval of Eli Lilly's Alzheimer's Drug Donanemab

Viking Therapeutics' New Weight Loss Drug Shows Promising Trial Results

Amylyx Pharmaceuticals Faces Class Action Lawsuits Over Misleading Statements

Biogen Discontinues Controversial Alzheimer's Drug Aduhelm

Gilead's Trodelvy Fails in Lung Cancer Trial, Stock Drops Over 10%

Spider Venom Molecule Shows Promise in Treating Heart Attacks and Strokes

GSK Acquires Aiolos Bio in $1.4 Billion Deal

Bristol Myers Squibb Acquires Karuna Therapeutics in $14 Billion Deal

FDA Panel Greenlights New Injection To Prevent Respiratory Virus in Infants